Importantly, similar to what has been described for CSF NFL, also serum NFL was shown to be already elevated in ALS patients presenting within 6 months from symptom onset, enabling excellent discrimination from MND mimics with AUC of 0.99 (Feneberg et al., 2018). This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.